Biological Activities of Caffeic Acid Phenethyl Ester: Comparative Analysis of Natural Products and Synthetic Derivatives

1.Context
Caffeic acid phenethyl ester (CAPE) is a bioactive compound found abundantly in phenolic acid species, particularly in propolis, where it serves as a potent antioxidant, antimicrobial, anti-inflammatory, and anticancer agent due to its phenolic structure. Alongside propolis and various plant products, CAPE’s biological activities have garnered attention in both traditional medicine and modern pharmacology [1]. The bioavailability and efficacy of natural CAPE may vary from its synthetic derivatives. Synthetic CAPE analogues have been synthesized to enhance bioavailability and act as specific modulators of biological targets, akin to analgesics. However, owing to its broad spectrum of biological effects and generally lower side effect profile, natural CAPE derived from complex biotic resins holds promise for further therapeutic and pharmaceutical applications [1]. This article seeks to compare the biological potentials and therapeutic uses of natural and synthetic CAPE, highlighting their respective advantages and limitations. Such insights aim to facilitate the development of more comprehensive strategies for the clinical application of CAPE and its integration into drug development processes [2].

1.1. CAPE and its properties
CAPE, a phenolic compound naturally found in bee products like propolis and certain plants, exhibits diverse biological effects due to its unique chemical structure. Foremost among its properties is its potent antioxidant capacity, which combats cell damage and slows aging processes by neutralizing free radicals. CAPE also possesses significant anti-inflammatory effects, suggesting potential applications in treating chronic diseases and inflammatory conditions [3].
Furthermore, CAPE demonstrates notable antimicrobial properties effective against various pathogens including bacteria, viruses, and fungi, positioning it as a natural preventive and therapeutic agent. Scientific studies also highlight CAPE’s potential as an anticancer agent, capable of inhibiting cancer cell growth and inducing apoptosis in some cases.
These multifaceted biological activities underscore CAPE’s importance in healthcare, whether derived naturally or synthetically. However, natural CAPE often offers broader and more reliable action with a generally lower risk of side effects compared to its synthetic counterparts. As such, the therapeutic potential of CAPE holds significant promise for ongoing research and future clinical applications [4]. Continued exploration of CAPE’s mechanisms and applications stands to enhance its role in preventive and therapeutic medicine, advancing treatment options for various diseases and conditions.

1.2. Derivatives and biosynthesis
CAPE derivatives are compounds engineered through structural modifications aimed at enhancing their biological activity or targeting specific therapeutic goals more effectively. These modifications involve the addition or alteration of chemical groups to the core structure of CAPE, which is synthesized by esterifying caffeic acid with phenethyl alcohol. Such alterations can enhance the bioavailability, cellular uptake, and overall activity of CAPE within target cells.
The biosynthesis of CAPE derivatives typically involves combining caffeic acid and phenethyl alcohol, sourced predominantly from natural origins, using chemical or enzymatic methods. Beyond naturally occurring CAPE and its derivatives, laboratory synthesis of derivatives has advanced through biotechnological and chemical engineering innovations [5].
These derivatives often exhibit enhanced biological activities compared to native CAPE, including stronger antioxidant, anti-inflammatory, antimicrobial, and anticancer properties. Some derivatives demonstrate improved selectivity against specific types of cancer or achieve higher efficacy with reduced toxicity. As a result, CAPE derivatives and their synthesis processes hold substantial promise for advancing new treatment modalities in modern medicine [6]. Continued research into CAPE derivatives is crucial for unlocking their full therapeutic potential and expanding treatment options across various medical applications.

1.3. Biological activities
CAPE derivatives are significant compounds that exhibit a range of biological activities due to the precise modification of their chemical structures. Derived from the natural form of CAPE, these derivatives have been developed to offer more effective and targeted therapies for various diseases. Their antioxidant properties enable them to protect cells from oxidative stress, thereby mitigating cellular damage caused by free radicals and potentially delaying signs of aging.
Moreover, CAPE derivatives exert potent anti-inflammatory effects, suppressing inflammatory processes and showing promise in the treatment of chronic inflammatory conditions. Their antimicrobial activities are also noteworthy, providing an effective defense against bacteria, viruses, and fungi, which enhances their utility in combating infections [7].
Of particular interest is their anticancer potential, where CAPE derivatives demonstrate the ability to inhibit cancer cell growth, prevent metastasis, and induce programmed cell death (apoptosis) in cancerous cells [7]. These multifaceted biological activities underscore the promising role of CAPE derivatives in pharmaceutical research and clinical applications. They not only hold potential for enhancing existing treatment methods but also for developing novel therapeutic strategies [8]. Continued research and development in CAPE derivatives are crucial for fully exploiting their therapeutic benefits and advancing medical interventions across diverse disease contexts.

1.3.1. Antioxidant activity
CAPE is a natural compound renowned for its potent antioxidant activity, crucial for protecting cells against oxidative stress induced by free radicals. These harmful molecules can inflict damage on cellular DNA, proteins, and lipids, contributing to the onset of various chronic diseases such as aging, cancer, cardiovascular disorders, and neurodegenerative conditions. CAPE’s phenolic structure enables it to effectively neutralize free radicals, thereby preventing oxidative damage [9].
Beyond its role in combating oxidative stress, CAPE’s antioxidant properties extend to reducing inflammation at the cellular level and promoting cellular longevity. This effect not only supports overall cellular health but also enhances immune function, contributing to the body’s resilience against various health challenges [9]. These beneficial properties position CAPE as a promising component in therapeutic applications aimed at mitigating skin aging, protecting heart health, and potentially slowing the progression of neurodegenerative diseases [8].
Research into CAPE’s antioxidant activity underscores its potential applications not only in pharmaceuticals and cosmetics but also in nutritional supplements. This versatility has propelled CAPE into the forefront of both scientific inquiry and industrial applications, highlighting its significance in promoting health and wellness across diverse domains [10]. As research continues to unveil its therapeutic potential, CAPE stands poised to make further strides in enhancing human health and longevity.

1.3.2. Antimicrobial activity
CAPE is a phenolic compound renowned for its potent broad-spectrum antimicrobial activity. This natural agent serves as an effective defense mechanism against a variety of pathogens including bacteria, viruses, and fungi. CAPE exerts its antimicrobial effects by disrupting the structural integrity of microbial cell membranes or inhibiting essential metabolic processes [11]. Notably, it demonstrates significant efficacy against both gram-positive and gram-negative bacteria, positioning it as a promising candidate for antibacterial therapies.
In combating viral infections, CAPE inhibits viral replication processes, thereby impeding the spread of viruses within the body. Its antiviral properties contribute to its potential application in combating viral illnesses. Furthermore, CAPE exhibits antifungal activity, particularly against Candida species, highlighting its versatility as a natural antimicrobial agent suitable for both prevention and treatment of infections. Importantly, CAPE’s natural origin suggests it carries fewer risks of adverse effects compared to synthetic antimicrobial agents, enhancing its reliability and preference in clinical use [12].

1.3.3. Anticancer and cytotoxic activities
CAPE has garnered significant attention in scientific research for its potent anticancer and cytotoxic activities. As a natural compound, CAPE demonstrates effectiveness against various types of cancer by inhibiting cancer cell growth, preventing metastasis, and inducing programmed cell death (apoptosis). It has shown promising results particularly in cancers of the colon, breast, prostate, and lung [13].
CAPE’s cytotoxic properties enable it to selectively target and damage cancer cells more effectively than healthy cells, potentially offering an alternative or complementary approach to traditional chemotherapy. Additionally, its antioxidant and anti-inflammatory properties contribute to reducing cancer progression and mitigating treatment-related side effects [14].
At the molecular level, CAPE exerts its anticancer effects through mechanisms such as cell cycle regulation, activation of apoptosis pathways, and inhibition of angiogenesis (the formation of new blood vessels). These actions collectively suppress tumor growth and enhance the vulnerability of cancer cells to treatment strategies [13]. The multifaceted anticancer and cytotoxic potentials of CAPE underscore its promise for developing innovative and effective therapeutic approaches in oncology. These findings provide a solid foundation for integrating CAPE into pharmaceutical formulations and clinical applications, offering targeted treatments with reduced adverse effects [15].

1.3.4. Anti-inflammatory activity
CAPE is esteemed for its potent anti-inflammatory properties, crucial in managing chronic inflammatory conditions that can lead to serious health issues such as heart disease, diabetes, arthritis, and certain cancers. While inflammation is a natural defense mechanism against infections and injuries, chronic inflammation poses significant risks to health. CAPE intervenes by regulating and suppressing inflammatory processes, specifically by inhibiting the production of pro-inflammatory cytokines and reducing the activity of inflammatory enzymes like COX-2 [16].
At the cellular level, CAPE targets key inflammatory pathways such as NF-κB and MAPK, pivotal in the initiation and perpetuation of inflammation. By modulating these pathways, CAPE effectively controls inflammatory responses and alleviates symptoms associated with inflammatory diseases. Additionally, CAPE’s antioxidant properties play a crucial role in mitigating inflammation induced by oxidative stress, further enhancing its anti-inflammatory efficacy [17].
Clinical and preclinical studies underscore CAPE’s beneficial effects in conditions like arthritis, inflammatory bowel disease, allergic reactions, and other chronic inflammatory disorders. These findings position CAPE as a promising candidate for anti-inflammatory drugs and treatment strategies, particularly due to its natural origin and favorable safety profile compared to synthetic anti-inflammatory agents [18].

1.4. Pharmacological and therapeutic potentials
CAPE possesses extensive pharmacological and therapeutic potential owing to its diverse biological activities. Renowned for its antioxidant, anti-inflammatory, antimicrobial, and anticancer properties, CAPE emerges as a versatile agent for treating various diseases. Its antioxidant activity protects cells from oxidative stress, thereby delaying signs of aging and reducing the risk of chronic diseases [19].
CAPE’s anti-inflammatory effects not only alleviate symptoms of inflammatory diseases but also contribute to overall health maintenance by reducing systemic inflammation. Its antimicrobial properties offer a natural defense against bacterial, viral, and fungal infections, addressing a critical need amidst rising antibiotic resistance. The anticancer potential of CAPE is rooted in its ability to inhibit cancer cell growth, halt metastasis, and induce apoptosis in cancerous cells, potentially complementing conventional cancer treatments [20].
Moreover, CAPE’s low toxicity profile and natural origin position it as a safe ingredient for pharmaceutical and clinical applications. Its broad-ranging biological effects present opportunities for developing novel drugs and enhancing current treatment modalities across various medical fields. The therapeutic promise of CAPE extends beyond specific disease treatments to promoting general health and well-being, highlighting its potential as a valuable asset in preventive medicine and healthcare [21]. Continued research into CAPE’s mechanisms and applications promises to unveil further therapeutic potentials, advancing its role in modern medicine.

1.5. Biotechnological potential
CAPE emerges as a natural compound with significant biotechnological potential, owing to its diverse array of biological activities that render it valuable across various industrial and medical applications. The antioxidant, anti-inflammatory, antimicrobial, and anticancer properties of CAPE make it particularly promising for biotechnological advancements [22].
In the realm of biotechnology, CAPE holds promise for enhancing and optimizing its production through innovative methods. This includes biotechnological approaches to scale up production, potentially making CAPE more accessible for pharmaceutical, cosmetic, and other industrial applications. By exploring biotechnological production techniques, such as fermentation or enzymatic synthesis, researchers aim to meet increasing demand sustainably and economically [22].
Moreover, biotechnology offers avenues to delve deeper into understanding and fine-tuning the biological activities of CAPE. Molecular biology and genetic engineering techniques can be employed to augment CAPE’s therapeutic effects or tailor CAPE derivatives for specific medical uses. This research not only enhances the efficacy of CAPE-based treatments but also expands its versatility in addressing various health challenges [23]. Furthermore, biotechnological advancements in CAPE production through biosynthetic pathways hold promise for diversifying its applications across industrial sectors and medical fields [22]. By leveraging biotechnological innovations, the reach and benefits of CAPE can be extended to a broader audience, facilitating its integration into novel biotechnological solutions and products.
In conclusion, the biotechnological potential of CAPE is poised to drive innovations that enhance production efficiency, expand application possibilities, and optimize therapeutic outcomes. Continued research and development in biotechnology are pivotal in realizing the full spectrum of benefits offered by this valuable natural compound.

2. Conclusion and Recommendations for Use
CAPE, derived from natural sources, exhibits diverse biological activities including antioxidant, antimicrobial, anti-inflammatory, and anticancer properties, making it a valuable compound in healthcare applications. Natural CAPE is favored over synthetic derivatives due to its broader spectrum of biological effects and lower incidence of adverse effects, enhancing its attractiveness for pharmaceutical and therapeutic uses.
In contemporary medicine and pharmacology, the pharmacological profile of natural CAPE presents significant advantages, particularly in its high bioavailability and favorable safety profile, pivotal for managing various diseases and promoting health maintenance. However, while synthetic CAPE analogues show potential for targeted therapeutic applications, further investigation is necessary to elucidate their bioavailability and safety profiles.
Future research efforts should focus on expanding the clinical applications of CAPE and refining drug development strategies. This includes comparative studies to evaluate the efficacy and safety of natural versus synthetic CAPE derivatives. Such advancements are crucial for optimizing the integration of CAPE into clinical practice, thereby maximizing its therapeutic potential across diverse medical conditions.
In summary, CAPE represents a promising natural compound with multifaceted therapeutic potentials. Through rigorous scientific exploration and innovation, we can leverage CAPE’s unique properties to advance healthcare interventions and improve patient outcomes in the future of certain diseases, but they need further investigation in terms of bioavailability and safety profile. In the future, further research and development is required for broader clinical applications of CAPE and drug development processes. This will enable CAPE to be used more effectively and safely in healthcare and maximize its potential health benefits.

Compliance with ethical guidelines
All ethical standards have been upheld in the preparation of this article.

Data availability
Data supporting this study’s findings are available from the corresponding author upon request.

Funding
This research did not receive any grant from funding agencies in the public, commercial, or non-profit sectors. 

Authors' contributions
All the authors contributed equally in preparation of the present study.

Conflict of interest
The authors declare no conflict of interest.

References

1. Yordanov Y. Caffeic acid phenethyl ester (CAPE): Pharmacodynamics and potential for therapeutic application. Pharmacia. 2019; 66(3):107-14. [DOI:10.3897/pharmacia.66.e38573]
2. Murtaza G, Karim S, Akram MR, Khan SA, Azhar S, Mumtaz A, et al. Caffeic acid phenethyl ester and therapeutic potentials. Biomed Res Int. 2014; 2014:145342. [DOI:10.1155/2014/145342][PMID]
3. Liao HF, Chen YY, Liu JJ, Hsu ML, Shieh HJ, Liao HJ, et al. Inhibitory effect of caffeic acid phenethyl ester on angiogenesis, tumor invasion, and metastasis. J Agric Food Chem. 2003; 51(27):7907- [DOI:10.1021/jf034729d][PMID]
4. Kulkarni NP, Vaidya B, Narula AS, Sharma SS. neuroprotective potential of caffeic acid phenethyl ester (CAPE) in CNS disorders: Mechanistic and therapeutic insights. Curr Neuropharmacol. 2021; 19(9):1401-15. [DOI:10.2174/1570159x19666210608165509][PMID]
5. Mirzaei S, Gholami MH, Zabolian A, Saleki H, Farahani MV, Hamzehlou S, et al. Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer. Pharmacol Res. 2021; 171:105759. [DOI:10.1016/j.phrs.2021.105759][PMID]
6. Zhang P, Tang Y, Li NG, Zhu Y, Duan JA. Bioactivity and chemical synthesis of caffeic acid phenethyl ester and its derivatives. Molecules. 2014; 19(10):16458-76. [DOI:10.3390/molecules191016458][PMID]
7. Silva H, Lopes NMF. Cardiovascular effects of caffeic acid and its derivatives: A comprehensive review. Front Physiol. 2020; 11:595516. [DOI:10.3389/fphys.2020.595516][PMID]
8. Pérez R, Burgos V, Marín V, Camins A, Olloquequi J, González-Chavarría I, et al. Caffeic acid phenethyl ester (cape): biosynthesis, derivatives and formulations with neuroprotective activities. Antioxidants. 2023; 12(8):1500. [DOI:10.3390/antiox12081500][PMID]
9. Olgierd B, Kamila Ż, Anna B, Emilia M. The pluripotent activities of caffeic acid phenethyl ester. Molecules. 2021; 26(5):1335. [DOI:10.3390/molecules26051335][PMID]
10. Pittalà V, Salerno L, Romeo G, Acquaviva R, Di Giacomo C, Sorrenti V. Therapeutic potential of caffeic acid phenethyl ester (CAPE) in diabetes. Curr Med Chem. 2018; 25(37):4827-36. [DOI:10.2174/0929867324666161118120908][PMID]
11. Celik S, Erdogan S, Tuzcu M. Caffeic acid phenethyl ester (CAPE) exhibits significant potential as an antidiabetic and liver-protective agent in streptozotocin-induced diabetic rats. Pharmacol Res. 2009; 60(4):270-6. [DOI:10.1016/j.phrs.2009.03.017][PMID]
12. Natarajan K, Singh S, Burke TR Jr, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc Natl Acad Sci U S A. 1996; 93(17):9090-5. [DOI:10.1073/pnas.93.17.9090][PMID]
13. Shih YH, Hsia SM, Chiu KC, Wang TH, Chien CY, Li PJ, et al. In vitro antimicrobial potential of CAPE and caffeamide derivatives against oral microbes. Int J Mol Sci. 2022; 23(8):4099. [DOI:10.3390/ijms23084099][PMID]
14. Khan F, Bamunuarachchi NI, Tabassum N, Kim YM. Caffeic acid and its derivatives: Antimicrobial drugs toward microbial pathogens. J Agric Food Chem. 2021; 69(10):2979-3004. [DOI:10.1021/acs.jafc.0c07579][PMID]
15. Taysi S, Algburi FS, Taysi ME, Caglayan C. Caffeic acid phenethyl ester: A review on its pharmacological importance, and its association with free radicals, COVID-19, and radiotherapy. Phytother Res. 2023; 37(3):1115-35. [DOI:10.1002/ptr.7707][PMID]
16. Ogeturk M, Kus I, Colakoglu N, Zararsiz I, Ilhan N, Sarsilmaz M. Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. J Ethnopharmacol. 2005; 97(2):273-80. [DOI:10.1016/j.jep.2004.11.019][PMID]
17. Kim H, Kim W, Yum S, Hong S, Oh JE, Lee JW, et al. Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: Structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation. Free Radic Biol Med. 2013; 65:552-62. [DOI:10.1016/j.freeradbiomed.2013.07.015][PMID]
18. Tolba MF, Omar HA, Azab SS, Khalifa AE, Abdel-Naim AB, Abdel-Rahman SZ. Caffeic acid phenethyl ester: A review of its antioxidant activity, protective effects against ischemia-reperfusion injury and drug adverse reactions. Crit Rev Food Sci Nutr. 2016; 56(13):2183-90. [DOI:10.1080/10408398.2013.821967][PMID]
19. Cho MS, Park WS, Jung WK, Qian ZJ, Lee DS, Choi JS, et al. Caffeic acid phenethyl ester promotes anti-inflammatory effects by inhibiting MAPK and NF-κB signaling in activated HMC-1 human mast cells. Pharm Biol. 2014; 52(7):926-32. [DOI:10.3109/13880209.2013.865243][PMID]
20. Márquez N, Sancho R, Macho A, Calzado MA, Fiebich BL, Muñoz E. Caffeic acid phenethyl ester inhibits t-cell activation by targeting both nuclear factor of activated t-cells and NF-κB transcription factors. J Pharmacol Exp Ther. 2004; 308(3):993-1001. [DOI:11124/jpet.103.060673][PMID]
21. Budisan L, Gulei D, Jurj A, Braicu C, Zanoaga O, Cojocneanu R, et al. Inhibitory Effect of CAPE and Kaempferol in colon cancer cell lines-possible implications in new therapeutic strategies. Int J Mol Sci. 2019; 20(5):1199. [DOI:10.3390/ijms20051199][PMID]
22. Wei X, Dai J, Zhong Y, Zhang D, Liu L, Wang L, et al. Caffeic acid phenethyl ester loaded in nano-targeted delivery system with casein: Physicochemical characterization, in vitro release, and binding mechanisms. LWT. 2021; 150:111938. [DOI:10.1016/j.lwt.2021.111938]
23. Vera J, González-Alcón C, Marín-Sanguino A, Torres N. Optimization of biochemical systems through mathematical programming: Methods and applications. Comput Oper Res. 2010; 37(8):1427-38. [DOI:10.1016/j.cor.2009.02.021]